Clinical Trials
4 trialsNCT02273219 2023-08-15
Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Columbia University
Phase 1 Completed
NCT01402440 2020-12-19
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Novartis
Phase 1 Terminated
NCT01430416 2020-12-19
Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Novartis
Phase 1 Completed
NCT01854606 2020-12-19
COEB071X2103
Novartis
Phase 1 Completed